Page 21«..10..20212223..3040..»

Category Archives: Clinical Cardiology

Alirocumab Shows Long-Term Safety and Efficacy in Patients With Statin Intolerance – The Cardiology Advisor

Posted: Published on April 29th, 2020

Alirocumab was found to be well tolerated and to produce long-term reductions in low-density lipoprotein cholesterol (LDL-C) in patients who are intolerant to statins, according to a study published in the Journal of Clinical Lipidology. Alirocumab is an inhibitor of proprotein convertase subtilisin/kexin type 9 Continue reading

Posted in Clinical Cardiology | Comments Off on Alirocumab Shows Long-Term Safety and Efficacy in Patients With Statin Intolerance – The Cardiology Advisor

Foreign doctors want to help fight the coronavirus. But the US health system stands in their way. – Vox.com

Posted: Published on April 29th, 2020

As the coronavirus pandemic continues to rip through the US, hard-hit areas have been facing doctor shortages, placing both patients and overworked health care workers at greater risk. Thousands of foreign doctors who already have clinical experience and are waiting for a chance to practice medicine in the US could step in to help. But even before the current crisis, the immigration system, coupled with medical licensing requirements, have made it difficult for them to work in the US and go where theyre needed Continue reading

Posted in Clinical Cardiology | Comments Off on Foreign doctors want to help fight the coronavirus. But the US health system stands in their way. – Vox.com

Percutaneous Left Axillary Artery Placement of IABP Found to Be Safe, Effective for Prolonged MCS in Advanced HF – The Cardiology Advisor

Posted: Published on April 29th, 2020

Percutaneous left axillary artery placement of an intra-aortic balloon pump (IABP) was found to be safe and effective for patients with advanced heart failure, according to study results published in JACC: Heart Failure. In patients who require prolonged mechanical circulatory bridge support (MCS), the placement of IABP transfemorally reduces mobility and ambulation, which can lead to increased risks for infection and debilitation. The alternative axillary approach has less impact on mobility compared with the femoral strategy Continue reading

Posted in Clinical Cardiology | Comments Off on Percutaneous Left Axillary Artery Placement of IABP Found to Be Safe, Effective for Prolonged MCS in Advanced HF – The Cardiology Advisor

Cardiac rehab tied to higher quality of life, study finds – Clinical Daily News – McKnight’s Long Term Care News

Posted: Published on April 29th, 2020

Heart attack patients who participate in cardiac rehabilitation have a higher self-reported quality of life than those who dont. And when they add on more physical activity they feel even better, according to a new study. Investigators recruited more than 4,500 patients admitted to British hospitals with a suspected heart attack between 2011 and 2013 Continue reading

Posted in Clinical Cardiology | Comments Off on Cardiac rehab tied to higher quality of life, study finds – Clinical Daily News – McKnight’s Long Term Care News

VA increases access to care for veterans through telehealth – WSAW

Posted: Published on April 29th, 2020

(WZAW) -- Telehealth services provided by the U.S. Department of Veterans Affairs are increasing access to care for veterans and helping to eliminate the need for patients to travel to the nearest VA facility for a variety of appointments. For many Veterans, using telehealth services is a viable option to provide care when and where they need it most. Continue reading

Posted in Clinical Cardiology | Comments Off on VA increases access to care for veterans through telehealth – WSAW

COVID-19: Getting the Information You Need, When You Need It – Medscape

Posted: Published on April 29th, 2020

This transcript has been edited for clarity. Continue reading

Posted in Clinical Cardiology | Comments Off on COVID-19: Getting the Information You Need, When You Need It – Medscape

Medpace Holdings, Inc. Reports First Quarter 2020 Results | Business – Olean Times Herald

Posted: Published on April 29th, 2020

CINCINNATI--(BUSINESS WIRE)--Apr 28, 2020-- Medpace Holdings, Inc. (Nasdaq: MEDP) (Medpace) today announced financial results for the first quarter ended March 31, 2020. First Quarter 2020 Financial Results Revenue for the three months ended March 31, 2020 increased 15.0% to $230.9 million, compared to $200.7 million for the comparable prior-year period. Continue reading

Posted in Clinical Cardiology | Comments Off on Medpace Holdings, Inc. Reports First Quarter 2020 Results | Business – Olean Times Herald

Managing ‘Vulnerable Subgroup’ With Diabetes and COVID-19 – MedicineNet

Posted: Published on April 29th, 2020

Miriam E. Tucker APRIL 28, 2020 -- An international panel of diabetes experts has published practical recommendations for managing diabetes in patients with COVID-19 both in and out of the hospital setting. The aim, they say, is to emphasize "the multiple challenges" healthcare professionals "from practitioners to intensive care staff might face in the management of .. Continue reading

Posted in Clinical Cardiology | Comments Off on Managing ‘Vulnerable Subgroup’ With Diabetes and COVID-19 – MedicineNet

Reduction in LV Mass With Empagliflozin Not Through Effect on LV Diastolic Function – The Cardiology Advisor

Posted: Published on April 25th, 2020

The reduction in left ventricular mass observed in patients with stable coronary artery disease and type 2 diabetes treated with empagliflozin may not result of an effect of this drug on diastolic function, according to results published in a letter to the editor in the Journal of the American Society of Echocardiography. Sodium-glucose cotransport protein 2 inhibitors such as empagliflozin have been shown to reduce heart failure hospitalization and cardiovascular death in clinical trials Continue reading

Posted in Clinical Cardiology | Comments Off on Reduction in LV Mass With Empagliflozin Not Through Effect on LV Diastolic Function – The Cardiology Advisor

Antimalarials widely used against COVID-19 heighten risk of cardiac arrest. How can doctors minimize the danger? – Science Magazine

Posted: Published on April 25th, 2020

Pharmaceutical manufacturers have ramped up production of chloroquine amid hopes that the antimalarial drug will prove effective against COVID-19. By Kelly ServickApr. 21, 2020 , 3:40 PM Sciences COVID-19 reporting is supported by the Pulitzer Center Continue reading

Posted in Clinical Cardiology | Comments Off on Antimalarials widely used against COVID-19 heighten risk of cardiac arrest. How can doctors minimize the danger? – Science Magazine

Page 21«..10..20212223..3040..»